P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib. (April 2023)

• Record Type: Journal Article
• Authors: Bartsch, R.; Harbeck, N.; Wrobel, D.; Zaiss, M.; Terhaag, J.; Guth, D.; Distelrath, A.; Wuerstlein, R.; Zahn, M.-O.; Lüftner, D.; Schwitter, M.; Balic, M.; Jackisch, C.; Müller, V.; Rinnerthaler, G.; Schmidt, M.; Zaman, K.; Schinköthe, T.; Gorray, M.; Breitenstein, U.
• Is Part Of: Breast. Volume 68(2023)
• Page Start: S20
• Page End: S21
• Publication Date: 2023-04
• Subjects: Breast -- Diseases -- Periodicals; Breast -- Tumors -- Periodicals; Breast -- Periodicals; Electronic journals; Periodicals; 616
• DOI: 10.1016/S0960-9776(23)00133-9
• Languages: English
• ISSNs: 0960-9776